Comprehensive Care for Joint Replacement (CJR)

Comprehensive Care for Joint Replacement (CJR)
Name	Comprehensive Care for Joint Replacement
Established	2016
Administered by	Centers for Medicare & Medicaid Services
Type	Bundled payment model
Jurisdiction	United States

Comprehensive Care for Joint Replacement (CJR) Comprehensive Care for Joint Replacement (CJR) is a Medicare payment model aimed at coordinating and improving care for beneficiaries undergoing hip and knee arthroplasty. The initiative links hospitals, surgeons, and post-acute providers to episode-based payments and quality metrics, involving federal agencies and private stakeholders in value-based payment reform. The program intersects with broader health policy efforts and has influenced bundled payment experiments across public and private sectors.

Overview

CJR was launched by the Centers for Medicare & Medicaid Services and announced during the administration of Barack Obama as part of efforts aligned with the Affordable Care Act payment reforms overseen by leaders such as Tom Price and Seema Verma. The model targeted selected metropolitan statistical areas including regions like Los Angeles, Chicago, and Houston and was piloted alongside programs such as the Bundled Payments for Care Improvement initiative. CJR episodes cover care from hospital admission through 90 days post-discharge for procedures such as total hip arthroplasty and total knee arthroplasty, involving stakeholders like American Academy of Orthopaedic Surgeons, American Hospital Association, and private payers including UnitedHealth Group and Aetna.

Program Design and Components

CJR implements an episode-based bundled payment tied to hospitals serving Medicare beneficiaries, incorporating components familiar from other models like Medicare Shared Savings Program and Accountable Care Organizations. Key elements include target pricing methodology influenced by historical fee-for-service claims data, reconciliation payments, and quality adjustment factors using measures similar to those from the National Quality Forum and the Joint Commission. Participating entities coordinate with post-acute sites such as Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, and home health agencies while aligning surgeon practices including those affiliated with systems like Mayo Clinic, Cleveland Clinic, and Massachusetts General Hospital.

Clinical Outcomes and Quality Measures

Clinical outcomes in CJR are assessed via readmission rates, complication rates, and patient-reported outcome measures akin to instruments promoted by the Agency for Healthcare Research and Quality, the Patient-Reported Outcomes Measurement Information System, and specialty registries such as the American Joint Replacement Registry. Quality measures include 90-day all-cause readmissions, mortality, and elective joint replacement complication rates, with benchmarking informed by claims analyses often conducted by research centers like RAND Corporation and Kaiser Permanente's Division of Research. Peer-reviewed evaluations from institutions like Harvard Medical School, Johns Hopkins University, and Stanford University have examined changes in utilization of post-acute care and trends in average episode spending.

Payment Model and Economics

CJR is a mandatory regional bundled payment model relying on retrospective reconciliation where hospitals receive or repay funds relative to predetermined benchmarks. Economic mechanisms draw on risk adjustment methods used in programs administered by the Centers for Medicare & Medicaid Services Innovation Center and actuarial approaches common to firms like Mercer and Milliman. Benchmarks consider regional historical spending and are influenced by coding and case-mix considerations addressed by stakeholders including the American Medical Association and the Office of Management and Budget. Analyses by economists at Brookings Institution, Urban Institute, and Health Affairs have debated cost savings, episode price compression, and downstream effects on volumes and patient selection.

Implementation and Operational Considerations

Operationalizing CJR required hospitals to develop care pathways, discharge planning protocols, and data sharing agreements with partners such as EPIC Systems Corporation and Cerner Corporation for electronic health record integration. Clinical leadership often involved orthopedic departments at institutions like Hospital for Special Surgery and program management by firms such as McKinsey & Company or Deloitte advising on population health and transitional care. Workforce training drew on guidelines from specialty societies including American Association of Hip and Knee Surgeons, while legal and compliance teams referenced statutes such as the Stark Law and the Anti-Kickback Statute during contracting with post-acute providers.

Policy, Regulation, and Adoption

Policy decisions around CJR intersected with federal rulemaking by the Department of Health and Human Services and regulatory commentary influenced by congressional oversight from committees like the House Committee on Ways and Means and the Senate Committee on Finance. Adoption and scaling decisions were informed by reports from Government Accountability Office and stakeholder feedback from organizations including AARP and Association of American Medical Colleges. Some commercial payers and state Medicaid programs, such as those in California and Michigan, examined CJR evidence to design their own bundled payment initiatives.

Criticisms and Future Directions

Critiques of CJR have come from academic critics at institutions such as Yale University and University of Pennsylvania who raised concerns about risk selection, impact on patient access, and adequacy of risk adjustment for social determinants of health studied by Robert Wood Johnson Foundation grantees. Policy analysts at Commonwealth Fund and commentators in New England Journal of Medicine have discussed alignment with alternative payment models like Direct Contracting and integration with value-based care trends driven by global payment pilots in systems like Geisinger Health System. Future directions include refinement of risk adjustment using social risk factors, expansion of voluntary bundled programs by private payers like Blue Cross Blue Shield Association, and integration with advanced outcome registries managed by entities such as ICD-10 Coordination and Maintenance Committee efforts and specialty registries.

Category:Medicare programs